A patent provides its owner with an exclusive right to a new invention. And beginning in the 1990s, the U.S. Patent and Trademark Office granted a multitude to OMRF, sometimes more than a dozen in a single year. Only a decade earlier did Congress give OMRF and others the right to patent inventions that stemmed […]
The road from laboratory discoveries to drugs to treat patients might more accurately be described as a treacherous mountain path. Many experiments that appear promising in a Petri dish don’t work in mice. And compounds that are safe and effective in rodents won’t necessarily prove out in people. The U.S. drug industry’s trade organization, the […]
Brain cancer survivor Mike Schuster celebrates a milestone he never thought possible.
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Directing money to in-state research was important to fundraisers.
Cutting off avenues for growth is key to killing tumors.